Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health.
As one of the industry’s top investors in Research and Development, the company focuses on developing innovative therapies in areas of high unmet medical need.
Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain.
More than 53,500 employees serve over 130 markets to build a healthier, more sustainable, and equitable tomorrow.
More information about Boehringer Ingelheim can be found at www.boehringer-ingelheim.com or in our annual report: www.annualreport.boehringer-ingelheim.com.
